EUPRAXIA PHARMACEUTICALS INC. Convertible Debt, Noncurrent
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Convertible Debt, Noncurrent of $8.74 million as of 2022-12-31, per its 40-F filed 2024-04-01.
Discontinued › Balance Sheet › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2024-04-01
- 2022-12-31: Convertible Debt, Noncurrent $8.74M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2022-12-31 | $8.74M 40-F · filed 2024-04-01 |